| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_504c36e633257227661d17d4fba83191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ddf43b24b359e4f6cd744dbeff5c444 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711 |
| filingDate |
1999-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a470f7fdb8e33fffbcd3c46d0b8a3ef9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6eec4ac9aa17e75e13cbdb49da618187 |
| publicationDate |
2001-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2380908-A1 |
| titleOfInvention |
Plasma substitute composition |
| abstract |
The invention relates to medicine and is particularly directed at pharmaceutical products used to treat serious, acute and chronic lesions of the human organism which cause heavy bleeding or a loss by the blood of its functional properties, together with immunodeficiency. A blood plasma replacement solution having an immunomodulating effect is disclosed. A physiologically acceptable salt of a DNA derivative may be used as a specific bioactive component, preferably a sodium salt obtained from animal raw materials such as the milt of salmonidae and of acipenseridae. Used in addition to the main treatment procedure, the inventive pharmaceutical product stimulates hematopoiesis and myelopoiesis without causing side effects. |
| priorityDate |
1999-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |